Cardiac dysfunction is a severe complication of anthracycline-containing anticancer therapy. The outcome of anthracycline-induced cardiomyopathy (AICM) compared with other non-ischaemic causes of heart failure (HF), such as idiopathic dilated cardiomyopathy (IDCM), is unresolved. The aim of this study was to compare the survival of AICM patients with an IDCM cohort followed at our centre from 1990 to 2016.
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience / Fornaro, Alessandra; Olivotto, Iacopo; Rigacci, Luigi; Ciaccheri, Mauro; Tomberli, Benedetta; Ferrantini, Cecilia; Coppini, Raffaele; Girolami, Francesca; Mazzarotto, Francesco; Chiostri, Marco; Milli, Massimo; Marchionni, Niccolò; Castelli, Gabriele. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - ELETTRONICO. - (2017), pp. 0-0. [10.1002/ejhf.1049]
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience
FORNARO, ALESSANDRA
;Olivotto, Iacopo;Rigacci, Luigi;Tomberli, Benedetta;Ferrantini, Cecilia;Coppini, Raffaele;Girolami, Francesca;MAZZAROTTO, FRANCESCO;Chiostri, Marco;Marchionni, Niccolò;Castelli, Gabriele
2017
Abstract
Cardiac dysfunction is a severe complication of anthracycline-containing anticancer therapy. The outcome of anthracycline-induced cardiomyopathy (AICM) compared with other non-ischaemic causes of heart failure (HF), such as idiopathic dilated cardiomyopathy (IDCM), is unresolved. The aim of this study was to compare the survival of AICM patients with an IDCM cohort followed at our centre from 1990 to 2016.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Fornaro_et_al-2017-European_Journal_of_Heart_Failure.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
802.03 kB
Formato
Adobe PDF
|
802.03 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
